Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

Tonix Pharmaceuticals is also enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
11/29/10 3 Moss David J 2
11/24/10 8-K Current report filing 2
11/08/10 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
11
08/09/10 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
11
05/04/10 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
11
02/16/10 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
21
01/21/10 8-K Current report filing 2
11/05/09 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
11
08/05/09 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
12
05/12/09 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
12